Obstetric Ultrasound: Artistry in Practice

Obstetric Ultrasound: Artistry in Practice

Volumn , Issue , 2008, Pages 1-195

  Hobbins, John C ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78650606828     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470696231     Document Type: Book

References (223)

1. Goldstein SR, Wolfson R. Endovaginal ultrasonographic measurement of early embryonic size as a means of assessing gestational age. J Ultrasound Med 1994; 13: 27-31.
2. Wilcox AJ, Weinberg CR, O'Connor JF, et al. Incidence of early loss in pregnancy. N Engl J Med 1988; 319: 189-94.
3. Benacerraf BR, Bromley B, Laboda LA, et al. Small sac in the first trimester: a predictor of poor fetal outcome. Radiology 1991; 178: 375-7.
4. Goldstein SR. Significance of cardiac activity in very early embryos. Obstet Gynecol 1992; 80: 670-2.
5. Benson CB, Doubilet PM. Embryonic heart rate in the early first trimester: what rate is normal? J Ultrasound Med 1995; 14: 431-4.
6. Papageorghiou AT, Avigdou K, Spencer K, et al. Sonographic screening for trisomy 13 at 11 to 136 weeks of gestation. Am J Obstet Gynecol 2006; 194: 397-401.
7. Kadar N, Caldwell BV, Romero R. A method of screening for ectopic pregnancy and its indicator. Obstet Gynecol 1981; 58: 162-6.
8. Goldstein SR, Snyder JR,WatsonC, et al. Very early pregnancy detectionwith endovaginal ultrasound. ObstetGynecol 1988; 72: 200-4.
9. Tong S, Wallace EM, Rombauts L. Association between low day 16 hCG and miscarriage after proven cardiac activity. Obstet Gynecol 2006; 107: 300-4.
10. Goldstein SR. Early detection of pathologic pregnancy by tran-svaginal sonography. J Clin Ultrasound 1990; 18: 262-73.
11. Ohno M, Maeda T, Matsunobu A. A cytogenetic study of spontaneous abortions with direct analysis of chorionic villi. Obstet Gynecol 1991; 77: 394-8.
12. Brown DI, Doubilet PM. Transvaginal sonography for diagnosing ectopic pregnancy: positivity criteria and performance characteristics. JUltrasoundMed1994; 13: 259-66.
13. Ankum WM, Hajenius PF, Schrevel LS, et al. Management of a suspected ectopic pregnancy. J Reprod Med 1996; 41: 724-8.
14. Souka AP, Pilalis A, Kavalakis I, et al. Screening for major structural anomalies at the 11-to-14 week ultrasound scan. Am J Obstet Gynecol 2006; 194: 393-6.
15. Hannah ME, Hannah WJ, Hewson SA, et al. Planned caesarean section versus planned vaginal birth at breech presentation at term: a randomized multicentre trial. Term Breech Trial Collaborative Group. Lancet 2000; 356: 1375-83.
16. Goffinet F, Carayol M, Foidart JM, et al. Is planned vaginal delivery forbreechpresentation at termstillanoption?Results of an observational prospective study in France and Belgium. Am J Obstet Gynecol 2006; 194: 1002-11.
17. Alarab M, Regan C, O'Connell MP, et al. Singleton vaginal breech delivery at term: still a safe option. Obstet Gynecol 2004; 103: 407-12.
18. Dashe JS, McIntire DD, Ramus RM, et al. Persistence of placenta previa according to gestational age at ultrasound detection. Obstet Gynecol 2002; 99: 692-7.
19. Becker RH, Vonk R, Mende BC, et al. The relevance of placental location at 20-23 gestational weeks for prediction of placenta previa at delivery evaluation of 8650 cases. Ultrasound Obstet Gynecol 2001; 17: 496-501.
20. Taipale P, Hiilesmaa B, Ylostalo P. Transvaginal ultrasound at 18-23 weeks in predicting placenta previa at delivery. Ultrasound Obstet Gynecol 1998; 12: 422-5.
21. Benirschke K, Kaufmann P, Baergen, R. Pathology of the Human Placenta, 5th ed. New York: Springer, 2006.
22. Oyelese Y, Catanzarite V, Prefumo F, et al. Vasa previa: the impact of prenatal diagnosis of outcomes. Obstet Gynecol 2004; 103: 937-42.
23. Schachter M, Tovbin Y, Arieli S, et al. In vitro fertilization is a risk factor for vasa previa. Fertil Steril 2002; 78: 642-3.
24. Clark SL,Koonings PP, Phelan JP. Placenta previa/accreta and poor cesarean section. Obstet Gynecol 1985; 66: 89-92.
25. FinbergHJ,Williams JW. Placenta accreta: perspective Sonographic diagnosis in patients with placenta previa and prior cesarean section. J Ultrasound Med 1992; 11: 333-43.
26. Comstock CH. Antenatal diagnosis of placenta accreta: a review. Ultrasound Obstet Gynecol 2005; 26: 89-96.
27. Kupferminc MJ, Tamura RK, Wigton TR, et al. Placenta accreta is associated with elevated maternal serum alphafetoprotein. Obstet Gynecol 1993; 82: 266-9.
28. Zelop C, Nadel A, Figoletto FD, et al. Placenta accreta/percreta/increta: a cause of elevated maternal serum alphafetoprotein. Obstet Gynecol 1992; 80: 693-5.
29. Abuhamad A, Sclater AJ, Carlson EJ, et al. Umbilical artery Doppler waveform notching: is it a marker for cord and placental abnormalities? J Ultrasound Med 2002; 21: 857-960.
30. Hasegawa J,Matsuoka R, Ichizuka K, et al. Velamentous cord insertion into the lower third of the uterus is associated with intrapartum fetal heart rate abnormalities. Ultrasound Obstet Gynecol 2006; 27: 425-9.
31. Grannum PA, Berkowitz RL, Hobbins JC. The ultrasonic changes in the maturing placenta and their relation to fetal pulmonic maturity. Am J Obstet Gynecol 1979: 133: 915-22.
32. Bricker L, Nielson JP. Routine ultrasound in late pregnancy. Cochrane Database Syst Rev 2000; CD001451.
33. Strong TH, Jarles VL, Vega JS, et al. The umbilical coiling index. Am J Obstet Gynecol 1994; 170: 29-32.
34. Persutte WH, Hobbins JC. Single umbilical artery: a clinical enigma in modern prenatal diagnosis. Ultrasound Obstet Gynecol 1995; 6: 216-29.
35. Sornes T. Umbilical cord encirclement and fetal growth restriction. Obstet Gynecol 1995; 86: 725-8.
36. Gonzalez-Quintero VH, Tolaymat L, Muller AC, et al. Outcomes of pregnancies with sonographically detected nuchal cords remote fromdelivery. JUltrasoundMed 2004; 23: 43-7.
37. Peregrine E, O'Brien P, Jauniaux E. Ultrasound detection of nuchal cord prior to labor induction and the risk of cesarian section. Ultrasound Obstet Gynecol 2005; 25:160-4.
38. Manning FA, Platt LP, Sipos L. Antepartum fetal evaluation: development of a fetal biophysical profile. Am J Obstet Gynecol 1980: 136: 787-95.
39. Phelan JM, Smith CV, Broussard P, et al. Amniotic fluid volume assessment with the four-quadrant technique at 36-42 weeks' gestation. J Reprod Med 1987; 32: 540-2.
40. Chauhan SP, Magann EF, Morrison JC, et al. Ultrasonic assessment of amniotic fluid does not reflect actual amniotic fluid volume. Am J Obstet Gynecol 1997; 177: 291-5.
41. Croom SC, Bonias BB, Ramos Santos E, et al. Do quantitative amniotic fluid indices reflect actual volume? Am J Obstet Gynecol 1992; 167: 995-9.
42. DildyGA III, LiraN,Moise KJ Jr, et al. Amniotic fluid volume assessment: comparison of ultrasonographic estimates versus direct measurements with dye-dilution technique in human pregnancy. Am J Obstet Gynecol 1992; 167: 986-94.
43. Bruner JP,ReedGW, SarnoAP, et al. Inter-observer variability and amniotic fluid index. Am J Obstet Gynecol 1993; 168: 1309-13.
44. Moore TR, Cayle JE. The amniotic fluid index in normal human pregnancy. Am J Obstet Gynecol 1990; 162: 1168-73.
45. Magann EF, Sanderson M, Martin JM, et al. The amniotic fluid index, single deepest pocket, and two-diameter pocket in normal human pregnancy. AmJObstetGynecol 2000; 182: 1581-8.
46. Magann SF, Chauhan SP, Barrilleaux PS, et al. Ultrasound estimate of amniotic fluid volume: colorDoppler overdiagnosis of oligohydramnios. Obstet Gynecol 2001; 98: 71-4.
47. Magann EF, Doherty DA, Field K, et al. Biophysical profile with amniotic fluid volume assessments. Obstet Gynecol 2004; 104: 5-10.
48. Gire C, Faggianelli P, Nicaise C, et al. Ultrasonographic evaluation of cervical length in pregnancies complicated by preterm premature rupture of membranes. Ultrasound Obstet Gynecol 2001; 19: 565-9.
49. Kilpatrick SJ, Safford KL, et al. Maternal hydration increases AFI in women with normal amniotic fluid. Obstet Gynecol 1993; 81: 49-52.
50. MalhotraB, Deka P. Duration of the increase in amniotic fluid index (AFI) after acute maternal hydration. Arch Gynecol Obstet 2004; 269: 173-5.
51. CaseyBM,McIntireDD,BloomSL, et al. Pregnancy outcomes after antepartum diagnosis of oligohydramnios at or beyond 34 weeks' gestation. Am J Obstet Gynecol 2000; 182: 909-12.
52. Conway DL, Adkins WB, Schroeder B, et al. Isolated oligohydramnios in the term pregnancy: is it a clinical entity? J Matern Fetal Med 1998; 7: 197-200.
53. Carlson DE, Platt LD, Medearis AL. The ultrasound triad of fetal hydramnios, abnormal hand posturing, and any other anomaly predicts autosomal trisomy. Obstet Gynecol 1992; 79: 731-4.
54. Espinoza J, Goncalves LF, Romero R, et al. The prevalence and clinical significance of amniotic fluid 'sludge' in patients with pretermlabor and intactmembranes. UltrasoundObstet Gynecol 2005; 25: 346-52.
55. Tan KBL, Tan TYT, Tan JVK, et al. The amniotic sheet: a truly benign condition? UltrasoundObstetGynecol 2005; 26: 639-43.
56. Qidwai GI, Caughey AB, Jacoby AF. Obstetric outcomes in womenwith sonographically identified uterine leiomyomata. Obstet Gynecol 2006; 107: 376-82.
57. Chauhan SP, Lutton PM, Bailey KH, et al. Intrapartum clinical, sonographic, and parous patients' estimates of newborn birth weight. Obstet Gynecol 1992; 79: 956-8.
58. Chervenak FA, Skupski DW, Romero R, et al. How accurate is fetal biometry in the assessment of fetal age? Am J Obstet Gynecol 1998; 178: 678-87.
59. Warda A, Deter RL, Duncan G, et al. Evaluation of fetal thigh circumference measurements: a comparative ultrasound and anatomical study. J Clin Ultrasound 1986; 14:99-103.
60. Lee W, Deter R, Ebersole JD, et al. Birth weight prediction by three-dimensional ultrasonography: fractional limb volume. J Ultrasound Med 2001; 20:1283-92.
61. Lindqvist PG, Molin J. Does antenatal identification of small-for-gestational age fetuses significantly improve their outcome? Ultrasound Obstet Gynecol 2005; 25: 258-64.
62. Campbell S, Thoms A. Ultrasound measurement of the fetal head to abdomen circumference ration in the assessment of growth retardation. Br J Obstet Gynaecol 1977; 84: 165-74.
63. Hadlock FP, Deter RL, Harrist RB, et al. A dateindependent predictor of intrauterine growth retardation: femur length/abdominal circumference. Am J Roentgenol 1983; 141: 979-84.
64. Giles WB, Trudinger BJ. Umbilical cord whole blood viscosity and the umbilical artery flow velocity time waveforms: a correlation. Br J Obstet Gynaecol 1986; 93: 466-70.
65. Divon MY. Umbilical artery Doppler velocimetry: clinical utility in high-risk pregnancies. Am J Obstet Gynecol 1996; 174: 10-14.
66. Alfirevic Z,Neilson JP. Doppler ultrasonography in high-risk pregnancies: systematic review with meta-analysis. AmJ Obstet Gynecol 1995; 172: 1379-87.
67. WestergaardHB, Langhoff-Roos J, Lingman G, et al. Acritical appraisal of the use of umbilical artery Doppler ultrasound high-risk pregnancies: use of metal-analysis in evidencebased obstetrics. Ultrasound Obstet Gynecol 2001; 17: 466-76.
68. Karsdorp VH, Dirks BK, van der Linden JC, et al. Placenta morphology and absent or reversed end diastolic flow velocities in the umbilical artery: a clinical and morphometrical study. Placenta 1996; 17: 393-9.
69. Karsdorp VHM, van Vugt JM, van Geijn HP, et al. Clinical significant of absent or reversed end diastolic velocity waveforms in umbilical artery. Lancet 1994; 344: 1664-8.
70. Soothill PW, Ajayi RA, Campbell S, et al. Fetal oxygenation at cordocentesis, maternal smoking and child neurodevelopment. Eur J Obstet Gynecol Reprod Biol 1995; 59: 21-4.
71. Ferrazzi E, Bozzo M, Rigano S, et al. Temporal sequence of abnormal Doppler changes in the peripheral and central circulatory systems of the severely growth-restricted fetus. Ultrasound Obstet Gynecol 2002; 19: 140-6.
72. Baschat AA, Gembruch U, Harmon CR. The sequent of changes in Doppler and biophysical parameters as several fetal growth restriction worsens. Ultrasound Obstet Gynecol 2001; 18: 571-7.
73. Hecher K,BilardoCM,Stigter RH, et al. Monitoring of fetuses with intrauterine growth restriction: a longitudinal study. Ultrasound Obstet Gynecol 2001; 18: 564-70.
74. Francisco RPV,Miyadahira S, Zugaib M, et al. Predicting pH at birth in absent or reverse end diastolic velocity in umbilical arteries. Obstet Gynecol 2006; 107: 1042-8.
75. PardiG,Cetin I,Marconi AM, et al. Diagnostic value of blood sampling and fetuses with growth retardation. N Engl J Med 1993; 328: 692-6.
76. Goldstein I, Copel JA, Makhoul EI. Mild cerebral ventriculomegaly in fetuses: characteristics and outcome. Fetal Diagn Ther 2005; 20: 281-4.
77. Breeze AC, Dey PK, Lees CC, et al. Obstetric and neonatal outcomes in apparently isolated mild fetal ventriculomegaly. J Perinat Med 2005; 33: 236-40
78. Gaglioti P, Danelon D, Bontempo S, et al. Fetal cerebral ventriculomegaly: outcome in 176 cases. Ultrasound Obstet Gynecol 2005; 25: 372-7.
79. Pilu G,Hobbins JC. Sonography of fetal cerebrospinal anomalies. Prenat Diag 2002; 22: 321-30.
80. Martin HP. Microcephaly and mental retardation. Am J Dis Child 1970; 119: 128-31.
81. Otto C, Platt LD.The fetal mandible measurement: an objective determination of fetal jaw size. Ultrasound Obstet Gynecol 1991; 1: 395-400.
82. Yagal S, Arbel R, Anteby EY, et al. The three vessels and trachea view (3VT) in fetal cardiac scanning. Ultrasound Obstet Gynecol 2002; 20: 340-5.
83. Ryu JM, KimMY, Choi HK, et al. Three-vessel view of the fetal upper mediastinum: an easy means of detecting abnormalities of the ventricular outflow tracts and great arteries during obstetric scanning. Ultrasound Obstet Gynecol 1997; 9: 173-82.
84. Tegnander E, Eik-Nes SH. The examiner's ultrasound experience has a significant impact on the detection rate of congenital heart defects at the second-trimester fetal examination. Ultrasound Obstet Gynecol 2006; 28: 8-14.
85. DeVore GR. Trisomy 21: 91% detection rate using secondtrimester ultrasound markers. Ultrasound Obstet Gynecol 2000; 16: 133-41.
86. DeVore GR, Polanco B, Sklansky MS, Platt LD. The 'spin' technique: a new method for examination of the fetal outflowtracts using three-dimensional ultrasound. Ultrasound Obstet Gynecol 2004; 24: 72-82.
87. Lennon CA, Gray Dl. Sensitivity and specificity of ultrasound for the detection of neural tube and ventral wall defects in a high-risk population. Obstet Gynecol 1999; 94: 562-6.
88. Simon-Bouy B, Mueller F. French Collaborative Group. Hyperechogenic fetal bowel and down syndrome: results of a French collaborative study based on 680 prospective cases. Prenat Diagn 2002; 22: 189-92.
89. Rochon M, Eddleman K. Controversial ultrasound findings. Obstet Gynecol Clin North Am 2004; 31: 61-99.
90. Achiron R, Seidman DA, Horowitz A, et al. Hyperechogenic fetal bowel and elevated serum alpha-fetoprotein: a poor fetal prognosis. Obstet Gynecol 1996; 88: 368-71.
91. Patel Y, Boyd PA, Chamberlain P, et al. Follow-up of children with isolated fetal echogenic bowel with particular reference to bowel-related symptoms. Prenat Diagn 2004; 24: 35-7.
92. Persutte WH, Hussey M, Chyu J, et al. Striking findings concerning the variability in the measurement of the fetal renal collecting system. Ultrasound Obstet Gynecol 2000; 15: 186-90.
93. Broadley T, McCugo J, Morgan I, et al. The 4 year outcome following the demonstration of bilateral renal pelvic dilatation on prenatal renal ultrasound. Br J Radiol 1999; 72: 265-70.
94. Dugoff L, Thieme G, Hobbins JC. Skeletal anomalies. Clin Perinatol 2000; 27: 979-1005.
95. SebireNJ, Snijders RJ,Hughes K, et al. The hidden mortality of monochorionic twin pregnancies. Br J Obstet Gynaecol 1997; 104(10): 1203-7.
96. Souka AP, Heath V, Flink S, et al. Cervical length at 23 weeks in twins in predicting spontaneous preterm delivery. Obstet Gynecol 1999; 94: 450-4.
97. Heath VC, Southall TR, Souka AP, et al. Cervical length at 23 weeks of gestation: prediction of spontaneous pretermdelivery. Ultrasound Obstet Gynecol 1998; 12: 312-7.
98. Monteagudo A, Timor-Tritsch IE (eds). Ultrasound andMultifetal Pregnancy. New York: Parthenon; 1998.
99. Sperling L, Kiil C, Larsen LU, et al. How to identify twins at low risk of spontaneous preterm delivery. Ultrasound Obstet Gynecol 2005; 26: 138-1444.
100. Quintero RA, Dickinson JE, Morales WJ et al. Stage-based treatment of twin-twin transfusion syndrome. Am J Obstet Gynecol 2003; 188: 1333-40.
101. National Center for Health Statistics. Vital statistics of the United States, Natality, 1974-1993.Hyattsville, MD: National Center for Health Statistics; 1977-1996.
102. Courtesy of Wapner RJ, Drexel University, Philadelphia, PA, USA.
103. Saura R, Gauthier B, Taine L, et al. Operator experience and fetal loss rate in transabdominal CVS. Prenat Diagn 1994; 14: 70-1.
104. Burton BK, Schulz CJ, Burd LI. Limb anomalies associated with chorionic villus sampling. ObstetGynecol 1992; 79: 726-30.
105. Froster UG, Jackson L. Limb defects and chorionic villus sampling: results froman international registry. Lancet 1996; 347: 489-94.
106. Tabor A, Madesen M, Obel E, et al. Randomized controlled trial of genetic amniocentesis in 4606 low-riskwomen. Lancet 1986; 1: 1287-93.
107. Seeds JW.Diagnostic mid-trimester amniocentesis: howsafe? Am J Obstet Gynecol 2004; 191: 608-16.
108. Wald NJ, Rodeck C, Hackshaw AR, et al. First and second trimester antenatal screening for Down's syndrome: the results in the Serum, Urine and Ultrasound Screening Study (SURUSS). Health Technol Assess 2003; 7: 1-77.
109. Nicolaides KH, Azar G, Byrne D, et al. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. Br Med J 1992; 304: 867-9.
110. Snijders RJ, Nobel P, Sebire N, et al. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. FetalMedicine Foundation First Trimester Screening Group. Lancet 1998; 352: 343-6.
111. Wapner R, Thom E, Simpson JL, et al. (for the First Trimester Maternal SerumBiochemistry and FetalNuchalTranslucency Screening (BUN) Study Group. First-trimester screening for trisomies 21 and 18. N Engl J Med 2003; 349: 1405-13.
112. Malone FD,Wald NJ, Canick JA, et al. (for the First and Second Trimester Evaluation of Risk (FASTER Trial)). First-and Second-Trimester Evaluation of Risk (FASTER) trial: principal results of the NICHD multicenter Down syndrome screening study. Am J Obstet Gynecol 2003; 189: S56.
113. Cicero S, Curcio P, Papageorghiou A, et al. Absence of nasal bone in fetuses with trisomy 21 at 11-14 weeks of gestation: an observational study. Lancet 2001; 358: 1665-7.
114. Cicero S, Longo D, Rembouskos G, et al. Absent nasal bone at 11-14 weeks of gestation and chromosomal defects. Ultrasound Obstet Gynecol 2003; 22: 31-5.
115. Falcon O, Auer M, Gerovassili, et al. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free β-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks. Ultrasound Obstet Gynecol 2006; 27: 151-5.
116. Matias A, Gomes C, Flack N, et al. Screening for chromosomal abnormalities at 10-14 weeks: the role of ductus venosus blood flow. Ultrasound Obstet Gynecol 1998; 12: 380-4.
117. Souka AP, Krampl E, Bakalis S, et al. Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester. UltrasoundObstetGynecol 2001; 18: 9-17.
118. Vintzileos AM. Screening for fetal chromosomal abnormalities, No 77. ACOG Practice Bulletin 2007; 109: 217-27.
119. Benacerraf BR, Barss VA, Laboda LA. A sonographic sign for the detection in the second trimester of the fetus with Down's syndrome. Am J Obstet Gynecol 1985; 151: 1078-9.
120. Hobbins JC, Lezotte DC, Persutte WH, et al. An 8-center study to evaluate the utility of midterm genetic sonograms amonghigh-risk pregnancies. JUltrasoundMed2003; 22: 33-8.
121. DeVore GR. The role of fetal echocardiography in genetic sonography. Semin Perinatol 2003; 27: 160-72.
122. Bromley B, Lieberman E, Laboda L, et al. Echogenic intracardiac focus: a sonographic sign for fetal Down syndrome. Obstet Gynecol 1995; 86: 998-1001.
123. Sotiriadis A,Makrydimas G, Ioannidis JP. Diagnostic performance of intracardiac echogenic foci for Down syndrome: a meta-analysis. Obstet Gynecol 2003; 101: 1009-16.
124. AndersonN, Jyoti R. Relationship of isolated fetal intracardiac echogenic focus to trisomy 21 at the mid-trimester sonogram in women younger than 35 years. UltrasoundObstetGynecol 2003; 21: 354-8.
125. Caughey AB, Lyell DJ, Filly RA, et al. The impact of the use of the isolated echogenic intracardiac focus as a screen for Down syndrome in women under the age of 35 years. Am J Obstet Gynecol 2001; 185: 1021-7.
126. Bromley B, Lieberman E, Shipp TD, et al. Fetal nose bone length: a marker for Down syndrome in the second trimester. J Ultrasound Med 2002; 21: 1387-94.
127. Persutte WH, Coury A, Hobbins JC. Correlation of fetal frontal lobe and transcerebellar diameter measurements: the utility of a new prenatal sonographic technique. Ultrasound Obstet Gynecol 1997; 10: 94-7.
128. ChitkaraU, Lee L, Oehlert JW, et al. Fetal ear length measurement: a useful predictor of aneuploidy? Ultrasound Obstet Gynecol 2002; 19: 131-5.
129. Benacerraf BR, Sathanondh R, Frigoletto FD. Sonographic demonstration of hypoplasia of the middle phalanx of the first digit: a finding associated with Down syndrome. Am J Obstet Gynecol 1988; 159: 181-3.
130. Egan JFX. The genetic sonogram in second trimester Down syndrome screening. Clin Obstet Gynecol 2003; 46: 897-908.
131. Shipp TD, Bromley B, Lieberman E, et al. The iliac angle as a sonographic marker forDown syndrome in second-trimester fetuses. Obstet Gynecol 1997; 89: 446-50.
132. Benacerraf BR, Mandell J, Estroff JA, et al. Fetal pyelectasis: a possible association with Down syndrome. Obstet Gynecol 1990; 76: 58-60.
133. Corteville JE, Dicke JM, Crane JP. Fetal pyelectasis and Down syndrome: is genetic amniocentesis warranted? Obstet Gynecol 1992; 79: 770-2.
134. Coco C, Jeanty P, Jeanty C. An isolated echogenic heart focus is not an indication for amniocentesis in 12,672 unselected patients. J Ultrasound Med 2004; 23: 489-96.
135. Malone F, Nyberg DA, Vidaver J, et al. (for the FASTER Research Consortium). First And Second Trimester Evaluation of Risk (FASTER) trial: the role of second trimester genetic sonography. [abstract] Am J Obstet Gynecol 2004; 191: S3.
136. Egan JF, Benn P, Borgida AF, et al. Efficacy of screening for fetal Down syndrome n the United States, from 1974 to 1997. Obstet Gynecol 2000; 96: 979-85.
137. DeMasio K, Canterino J, Ananth C, et al. Isolated choroid plexus cyst in low-risk women less than 35 years old. Am J Obstet Gynecol 2003; 187: 1246-9.
138. Yeo L, Guzman ER, Ananth CV, et al. Prenatal detection of fetal trisomy 18 through abnormal sonographic features. J Ultrasound Med 2003; 22: 581-90.
139. Bromley B, Lieberman E, Benacerraf B. Choroid plexus cysts: not associated with Down syndrome. Ultrasound Obstet Gynecol 1996; 8: 232-5.
140. Miller E, Hare JW, Cloherty JP, et al. Elevated maternal hemoglobin A1c in early pregnancy and major congenital anomalies and infants of diabetic mothers. N Engl J Med 1981; 304: 1331-4.
141. Sheffield JS, Butler-Koster EL, Casey BM, et al. Maternal diabetes mellitus and infant malformations. Obstet Gynecol 2002; 100: 925-30.
142. Hyett JA. Increased nuchal translucency in fetuseswith a normal karyotype. Prenat Diagn 2002; 22: 864-8.
143. Gabbe SG,Mestman JH, Freeman RK, et al. Management and outcome of class A diabetes mellitus. Am J Obstet Gynecol 1977; 127: 465-9.
144. Greco P, Vimercati A, Scioscia M, et al. Timing of fetal growth acceleration inwomenwith insulin-dependent diabetes. Fetal Diagn Ther 2003; 18: 437-41.
145. Mongelli M, Benzie R. Ultrasound diagnosis of fetal macrosomia: a comparison of weight prediction models using computer simulation. Ultrasound Obstet Gynecol 2005; 26: 500-3.
146. Abramowicz JS, Rana S, Abramowicz S. Fetal check-to-cheek diameter in the prediction of mode of delivery. Am J Obstet Gynecol 2005; 182: 1205-11.
147. Elliott JP, Garite TJ, Freeman RK, et al. Ultrasonic prediction of fetal macrosomia in diabetic patients. ObstetGynecol 1982; 60: 159-62.
148. Cohen B, Penning S, Major C, et al. Sonographic prediction of shoulder dystocia in infants of diabetic mothers. Obstet Gynecol 1996; 88: 10-3.
149. Winn HN, Holcomb W, Shumway JB, et al. The neonatal bisacromial diameter: a prenatal sonographic evaluation. J Perinat Med 1997; 25: 484-7.
150. Conway DL, Langer O. Elective delivery of infants with macrosomia in diabeticwomen:reduce shoulderdystocia versus increased cesarean deliveries. Am J Obstet Gynecol 1998; 178: 922-5.
151. Miller E, Hare JW, Cloherty JP, et al. Elevated maternal hemoglobin A1c in early pregnancy and major congenital anomalies and infants of diabetic mothers. N Engl J Med 1981; 304: 1331-4.
152. Sheffield JS, Butler-Koster EL, Casey BM, et al. Maternal diabetes mellitus and infant malformations. Obstet Gynecol 2002; 100: 925-30.
153. Hyett JA. Increased nuchal translucency in fetuseswith a normal karyotype. Prenat Diagn 2002; 22: 864-8.
154. Gabbe SG,Mestman JH, Freeman RK, et al. Management and outcome of class A diabetes mellitus. Am J Obstet Gynecol 1977; 127: 465-9.
155. Greco P, Vimercati A, Scioscia M, et al. Timing of fetal growth acceleration inwomenwith insulin-dependent diabetes. Fetal Diagn Ther 2003; 18: 437-41.
156. Mongelli M, Benzie R. Ultrasound diagnosis of fetal macrosomia: a comparison of weight prediction models using computer simulation. Ultrasound Obstet Gynecol 2005; 26: 500-3.
157. Abramowicz JS, Rana S, Abramowicz S. Fetal check-to-cheek diameter in the prediction of mode of delivery. Am J Obstet Gynecol 2005; 182: 1205-11.
158. Elliott JP, Garite TJ, Freeman RK, et al. Ultrasonic prediction of fetal macrosomia in diabetic patients. ObstetGynecol 1982; 60: 159-62.
159. Cohen B, Penning S, Major C, et al. Sonographic prediction of shoulder dystocia in infants of diabetic mothers. Obstet Gynecol 1996; 88: 10-3.
160. Winn HN, Holcomb W, Shumway JB, et al. The neonatal bisacromial diameter: a prenatal sonographic evaluation. J Perinat Med 1997; 25: 484-7.
161. Conway DL, Langer O. Elective delivery of infants with macrosomia in diabeticwomen:reduce shoulderdystocia versus increased cesarean deliveries. Am J Obstet Gynecol 1998; 178: 922-5.
162. Iams JD, Goldenberg RL, Meis PJ, et al. The length of the cervix and the risk of spontaneous premature delivery. National Institute of Child Health and Human Development Maternal fetal medicine Unit Network. N Engl J Med 1996; 334: 567-72.
163. Heath VC, Southall TR, Souka AP, et al. Cervical length at 23weeks of gestation: prediction of spontaneous pretermdelivery. Ultrasound Obstet Gynecol 1998; 12: 312-7.
164. Zilianti M, Azuaga A, Calderon F, et al. Monitoring the effacement of the uterine cervix by transperineal sonography: a new perspective. J Ultrasound Med 1995; 14: 719-24.
165. Yoshimatsu K, Sekiya T, Ishihara K, et al. Detection of the cervical gland area in threatened preterm labor using transvaginal sonography in assessment of cervical maturation and the outcome of pregnancy. Gynecol Obstet Invest 2002; 53: 149-56.
166. Hassan SS, Romero R, Berry SM, et al. Patients with an ultrasonographic cervical length of < or = 1.5 mm have nearly a 50% risk of early spontaneous preterm delivery. Am J Obstet Gynecol 2000; 182: 1458-67.
167. Althuisius S, Dekker G. Controversies regarding cervical incompetence, short cervix, and the need for cerclage. Clin Perinatol 2004; 31: 695-720.
168. Kurtzman JT, Jenkins SM, Brewster WR. Dynamic cervical change during real-time ultrasound: prospective characterization and comparison in patients with and without symptoms of preterm labor. Ultrasound Obstet Gynecol 2004; 23: 574-8.
169. Guzman ER, Vintzileos AM, McLean DA, et al. The natural history of a positive response to transfundal pressure in women at risk for cervical incompetence. Am J Obstet Gynecol 1997; 176: 634-8.
170. Romero R, Gonzalez R, SepulvedaW, et al. Infection and labor. VIII.Microbial invasion of the amniotic cavity in patients with suspected cervical incompetence: prevalence and clinical significance. Am J Obstet Gynecol 1992; 167: 1086-91.
171. Gomez R, Romero R, Nien JK, et al. A short cervix in women with preterm labor and intact membranes: a risk factor for microbial invasion of the amniotic cavity. Am J Obstet Gynecol 2005; 192: 678-89.
172. Hassan S, Romero R, Hendler I, et al. A Sonographic short cervix as the only clinical manifestation of intra-amniotic infection. J Perinat Med 2006; 34: 13-9.
173. Crane JM, Delaney T, Hutchens D. Transvaginal ultrasonography in the prediction of preterm birth after treatment for cervical intraepithelial neoplasia. Obstet Gynecol 2006; 107: 37-44.
174. Rush RW, Isaacs S,McPherson K, et al. A randomized control trial of cervical cerclage in women at high risk of spontaneous preterm delivery. Br J Obstet Gynaecol 1984; 91: 724-30.
175. Lazar P,Gueguen S,Dreyfus J, et al. Multicentred control trial of cervical cerclage in women at moderate risk for preterm delivery. Br J Obstet Gynaecol 1984; 91: 731-5.
176. Final multicentre report of Medical Research Council/Royal College ofObstetricians andGynaecologists randomized trial of cervical cerclage. MRC/RCOGWorking Party on Cervical Cerclage. Br J Obstet Gynaecol 1993; 100: 516-23.
177. Drakeley A, Roberts D, Alfirevic Z. Cervical cerclage for prevention of pretermdelivery:meta-analysis of randomized trials. Am J Obstet Gynecol 2003; 102: 621-7.
178. Althuisius SM, Dekker GA, Hummel P, et al. Final results of the Cervical Incompetence prevention Randomized Cerclage Trial (CIPRACT): therapeutic cerclage with bed rest versus bed rest alone. Am J Obstet Gynecol 2001; 185: 1106-12.
179. Berghella V, Odibo AD, To MS, et al. Cerclage for short cervix on ultrasound: meta-analysis of trials using individual patient-level data. Obstet Gynecol 2005; 106: 181-9.
180. Sakai M, Shiozaki A, Tabata M, et al. Evaluation of effectiveness of prophylactic cerclage of a short cervix according to interleukin-8 and cervical mucus. Am J Obstet Gynecol 2006; 194: 14-9.
181. Olatunbosun OA, al-Nuaim L, Turnell RW. Emergency cerclage compared with bed rest for advanced cervical dilation in pregnancy. Int Surg 1995; 80: 170-4.
182. Tsoi E, Akmal S, Rane S, et al. Ultrasound assessment of cervical length in threatened preterm labor. Ultrasound Obstet Gynecol 2003; 21: 552-5.
183. Fuchs IB, Henrich WO, Osthues K, et al. Sonographic cervical length in singleton pregnancies with intact membranes presentingwith threatened pretermlabor. UltrasoundObstet Gynecol 2004; 24: 554-7.
184. Daskalakis G, Thomakos N, Hatziioannou L, et al. Cervical assessment inwomenwith threatened pretermlabor. JMatern Fetal Neonatal Med 2005; 17: 309-12.
185. Gomez R, Romero R, Medina L, et al. Cervicovaginal fibronectin improves the prediction of preterm delivery based on sonographic cervical length in patients with pretermuterine contractions and intact membranes. AmJObstetGynecol 2005; 92: 350-9.
186. Odibo AO, TalucciM, Berghella V. Prediction of pretermpremature rupture of membranes by transvaginal ultrasound features and risk factors in a high-risk population. Ultrasound Obstet Gynecol 2002; 20: 245-51.
187. Gire C, Fabbianelli P, Nicaise C, et al. Ultrasonographic evaluation of cervical length in pregnancies complicated by preterm premature rupture of membranes. Ultrasound Obstet Gynecol 2002; 19: 565-9.
188. Vintzileos AM, CampbellWA, Nochimson DJ, et al. The fetal biophysical profile in patients with premature rupture of the membranes-an early predictor of fetal infection. Am J Obstet Gynecol 1985; 152: 510-6.
189. Queenan JT, Tomai TP, Ural SH, King JC. Deviation in amniotic fluid optical density at a wavelength of 450 nm in Rhimmunized pregnancies from 14 to 40 weeks' gestation: a proposal for clinical management. Am J Obstet Gynecol 1993; 168:1370-76.
190. Mari G, Deter RL, Carpenter RL. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal redcell alloimmunization. Collaborative Group for Doppler Assessment of the BloodVelocity inAnemic Fetuses. JUltrasound Med 2005; 24: 1599-624.
191. Weiner CP, Manogura AC. Maternal alloimmunization and fetal hemolytic disease. In: Clinical Obstetrics: The Fetus and Mother. Reece EA, Hobbins JC (eds). Malden, MA: Blackwell Publishing, 2007.
192. Goncalves L, Lee W, Espinosa J, et al. Three-and 4-dimensional ultrasound in obstetric practice: does it help? J Ultrasound Med 2005; 24: 1599-624.
193. Wang PH, Ying TH, Wang PC, et al. Obstetrical threedimensional ultrasound in the visualization of the intracranial midline in corpus callosum of fetuses in cephalic presentation. Prenat Diagn 2000; 20: 518-20.
194. Benacerraf BR, Shipp TD, Bromley B. Improving the efficiency of gynecologic sonography with 3-dimensional volumes: a pilot study. J Ultrasound Med 2006; 25: 165-71.
195. Benacerraf BR, Shipp TD, Bromley B. How sonographic tomography will change the face of fetal ultrasound: a pilot study. J Ultrasound Med 2005: 24: 371-8.
196. RuanoR, Joubin L, SonigoP, et al. Fetal lungvolumeestimated by 3-dimensional ultrasonography and magnetic resonance imaging in cases with isolated congenital diaphragmatic hernia. J Ultrasound Med 2004; 23: 353-8.
197. Kalache KD, Espinoza J, Chaiworapongsa T, et al. Threedimensional ultrasound fetal lung volume measurement: a systematic study comparing themultiplanar methodwith the rotational (VOCAL) technique. Ultrasound Obstet Gynecol 2003; 21: 111-8.
198. Moeglin D, Talmant C, Dyme M, et al. Fetal lung volumetry using two-and three-dimensional ultrasound. Ultrasound Obstet Gynecol 2005; 25: 119-27.
199. Jeanty P, Romero R, Hobbins JC. Fetal limb volume: a new parameter to assess fetal growth and nutrition. J Ultrasound Med 1985; 4: 273-82.
200. LeeW, Deter R, Ebersole JD, et al. Birth weight prediction by three-dimensional ultrasonography: fractional limb volume. J Ultrasound Med 2001; 20: 1283-92.
201. Campbell S, Reading AE, Cox DN, et al. Ultrasound scanning in pregnancy: the short termpsychological effects of early real time scans. J Psychosom Obstet Gynaecol 1982; 1: 57-61.
202. Ji EK, Pretorius DH, Newton R, et al. Effects of ultrasound on maternal-fetal bonding: a comparison of two-and threedimensional imaging. Ultrasound Obstet Gynecol 2005; 25: 473-7.
203. Rustico MA, Mastromatteo C, Grigio M, et al. Twodimensional vs. two-plus four-dimensional ultrasound in pregnancy and the effect on maternal emotional status: a randomized study. Ultrasound Obstet Gynecol 2005; 25: 468-72.
204. Sedgmen B,McMahon C, Cairns D, et al. The impact of twodimensional versus three-dimensional ultrasound exposure on maternal-fetal attachment and maternal health behavior in pregnancy. Ultrasound Obstet Gynecol 2006; 27: 245-51.
205. Campbell S. 4D and prenatal bonding: still more questions than answers. Ultrasound Obstet Gynecol 2006; 27: 243-4.
206. Salvesen KA, Vatten LJ, Eik-Nes SH, et al. Routine ultrasonography in utero and subsequent handedness and neurological development. BMJ 1993; 307: 159-64.
207. Salvesen KA, Eik-Nes SH. Ultrasound during pregnancy and subsequent childhood non-right handedness: ameta-analysis. Ultrasound Obstet Gynecol 1999; 13: 241-6.
208. Newnham JP, Evans SF, Michael CA, et al. Effects of frequent ultrasound during pregnancy: a randomized controlled trial. Lancet 1993; 342: 887-91.
209. NewnhamJP,DohertyDA,Kendall GE, et al. Effects of repeated prenatal ultrasound examinations on childhood outcome up to 8 years of age: follow-up of a randomized controlled trial. Lancet 2004; 364: 2038-44.
210. Ang ES Jr, Gluncic V, Duque A, et al. Prenatal exposure to ultrasound waves impacts neuronal migration in mice. Proc Natl Acad Sci USA 2006; 103: 12903-10.
211. AIUM Practice Guidelines for the Performance of an Antepartum Obstetric Ultrasound Examination. Laurel, MD: American Institute of Ultrasound in Medicine; 2007; 1-13.
212. AIUM Official Statement: Prudent Use and Clinical Safety. Laurel, MD: American Institute of Ultrasound in Medicine; Approved March 19, 2007.
213. AIUM Official Statement: Limited Obstetrical Ultrasound. Laurel, MD: American Institute of Ultrasound in Medicine; Approved October 7, 1997.
214. Manning FA, Platt LD, Sipos L. Antepartum fetal evaluation: development of a fetal biophysical profile. AmJObstetGynecol 1980; 136: 787-95.
215. Patrick J, Carmichael L, Chess L, et al. Accelerations of the human fetal heart rate at 38 to 40 weeks' gestational age. Am J Obstet Gynecol 1984; 148: 35-41.
216. Hanley ML, Vintzileos AM. Antepartum and intrapartum surveillance of fetal well-being. In: Reece EA, Hobbins JC (eds.),Medicine of the Fetus andMother, 2nd ed. Philadelphia, PA: Lippincott-Raven Publishers, 1999.
217. Vintzileos AM, Fleming AD, Scorza WE, et al. Relationship between fetal biophysical activities and umbilical cord blood gas values. Am J Obstet Gynecol 1991; 165: 707-13.
218. Miller DA, Rabello YA, Paul RH. The modified biophysical: antepartum testing in the 1990's. Am J Obstet Gynecol 1996; 174: 812-7.
219. Baschat AA, Galan HL, Bhide A, et al. Doppler and biophysical assessment in growth restricted fetuses: distribution of results. Ultrasound Obstet Gynecol 2006; 27: 41-7.
220. Macones GA, Cahill AG, Stamilio DM, et al. Can uterine rupture in patients attempting vaginal birth after cesarean delivery be predicted? Am J Obstet Gynecol 2006; 195: 1148-52.
221. Gotoh H,Masuzaki H, Yoshida A, et al. Predicting incomplete uterine rupturewith vaginal sonography during the late second trimester inwomenwith priorCesarean. ObstetGynecol 2000; 95: 596-600.
222. Rozenberg P, Goffinet F, Philippe HJ, et al. Ultrasonographic measurement of lower uterine segment to assess risk of defects of scarred uterus. Lancet 1996; 347: 281-4.
223. Goldstein I, Lockwood CJ, Reece EA, et al. Sonographic assessment of the distal femoral and proximal tibial ossification centers in the prediction of pulmonic maturity in normal women and women with diabetes. Am J Obstet Gynecol 1988; 159: 72-6.